Where does Epitomics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Epitomics, Inc. ranks #21,101 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Epitomics, Inc. hold?

Epitomics, Inc. holds 13 US utility patents granted between 2015 and 2023, spanning 8 technology areas.

What is Epitomics, Inc.'s Innovation Score?

Epitomics, Inc. has an Innovation Score of 30.6 out of 100 (35th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Epitomics, Inc. focus on?

Epitomics, Inc.'s top technology area is C07K (Peptides) with 12 patents, ranking #755 of 3,615 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Epitomics, Inc.'s patent grant rate increasing or decreasing?

Epitomics, Inc.'s recent grant velocity is -70% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Epitomics, Inc.'s patents?

Epitomics, Inc.'s patents average 16.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Epitomics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Epitomics, Inc.

USPTO PatentsView assignee record - 13 granted patents across 8 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Epitomics ranks #21,101 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 8 technology areas.

#21,101
of 49,997 US assignees by volume: 35th percentile
by Innovation Score (30.6/100): 16.4
avg claims per patent: -70%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21101 · US Corporation #21,101 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #21,101/49,997
PHOTO-FINISH Enpulz
CPC-NARROW C07K · 8 areas
INNOV-THIN 30.6/100
CLAIMS-RICH 16.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -70% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Enpulz, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Epitomics’s 30.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (30%) Velocity 1.7 pts (6%) Breadth 10.0 pts (33%) Claim depth 9.8 pts (32%)

Qualcomm Incorporated · highest

85
Epitomics · this assignee

31
3D Lighting… · lowest

7

What this shows Epitomics's Innovation Score is 30.6/100 (35th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Epitomics?

Each dot is one of Epitomics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Epitomics’s own 16.4 claims/patent is at or below the 17.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Epitomics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Epitomics's grants concentrate

Epitomics, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 92.3% of grants classified under C07K (Peptides). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2017. By volume, Epitomics sits between Enpulz, LLC and Essentially Engineered, LLC.

Epitomics's three-year grant acceleration

Epitomics, Inc. shows 1 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Enpulz

13
Enve Composites

13
Envia Systems

13
Envision Digital…

13
Equipmentshare COM

13
Ermi

13
Essence Technolog…

13
Essentially Engin…

13
Epitomics ◀

13

What this shows Epitomics holds 13 patents at rank #21,066, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Epitomics

By rank, the assignees closest to #21,066 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Epitomics's primary technology class.

Epitomics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 35th percentile higher than 35% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Epitomics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	30.8%
2016	3	23.1%
2017	1	7.7%
2019	2	15.4%
2020	1	7.7%
2021	1	7.7%
2023	1	7.7%

Which technologies does Epitomics, Inc. patent most?

C07K - Peptides 12

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 4

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Epitomics, Inc.'s patent record in context - here's where to go next.

Epitomics, Inc.'s lead technology class is C07K (Peptides), 92.3% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #21,101 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Epitomics, Inc. against Enpulz, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.